HRP20161424T1 - Supstituirani 6-amino-nikotinamidi koji nose skupinu koja sadrži oh kao modulatori kcnq2/3 - Google Patents
Supstituirani 6-amino-nikotinamidi koji nose skupinu koja sadrži oh kao modulatori kcnq2/3 Download PDFInfo
- Publication number
- HRP20161424T1 HRP20161424T1 HRP20161424TT HRP20161424T HRP20161424T1 HR P20161424 T1 HRP20161424 T1 HR P20161424T1 HR P20161424T T HRP20161424T T HR P20161424TT HR P20161424 T HRP20161424 T HR P20161424T HR P20161424 T1 HRP20161424 T1 HR P20161424T1
- Authority
- HR
- Croatia
- Prior art keywords
- aliphatic residue
- residue
- unsubstituted
- polysubstituted
- mono
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12002709 | 2012-04-18 | ||
| PCT/EP2013/001134 WO2013156154A1 (en) | 2012-04-18 | 2013-04-17 | Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
| EP13719386.8A EP2888233B1 (en) | 2012-04-18 | 2013-04-17 | Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161424T1 true HRP20161424T1 (hr) | 2016-12-16 |
Family
ID=48227140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161424TT HRP20161424T1 (hr) | 2012-04-18 | 2013-04-17 | Supstituirani 6-amino-nikotinamidi koji nose skupinu koja sadrži oh kao modulatori kcnq2/3 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP2888233B1 (enExample) |
| JP (1) | JP6033403B2 (enExample) |
| CN (1) | CN104428287A (enExample) |
| AR (1) | AR090739A1 (enExample) |
| AU (1) | AU2013248637A1 (enExample) |
| BR (1) | BR112014025840A2 (enExample) |
| CA (1) | CA2870573A1 (enExample) |
| CY (1) | CY1118255T1 (enExample) |
| DK (1) | DK2888233T3 (enExample) |
| EA (1) | EA201401142A1 (enExample) |
| ES (1) | ES2605947T3 (enExample) |
| HK (1) | HK1210173A1 (enExample) |
| HR (1) | HRP20161424T1 (enExample) |
| HU (1) | HUE030859T2 (enExample) |
| IL (1) | IL235030A0 (enExample) |
| LT (1) | LT2888233T (enExample) |
| MX (1) | MX2014012494A (enExample) |
| PT (1) | PT2888233T (enExample) |
| RS (1) | RS55466B1 (enExample) |
| SI (1) | SI2888233T1 (enExample) |
| WO (1) | WO2013156154A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3447047A1 (en) * | 2016-04-22 | 2019-02-27 | ONO Pharmaceutical Co., Ltd. | Crystal polymorphism of kcnq 2-5 channel activator |
| WO2019130185A1 (en) * | 2017-12-29 | 2019-07-04 | 3M Innovative Properties Company | Thermally curable two part processing adhesive composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2230392A1 (de) | 1972-06-22 | 1974-01-31 | Cassella Farbwerke Mainkur Ag | Substituierte pyridinverbindungen und verfahren zu ihrer herstellung |
| DE2513949A1 (de) | 1975-03-29 | 1976-10-07 | Bayer Ag | Azofarbstoffe |
| CZ20032233A3 (cs) | 2001-02-20 | 2004-12-15 | Bristol-Myers Squibb Company | Derivát 2,4-disubstituovaného pyrimidin-5-karboxamidu jako modulátor draslíkového kanálku KCNQ |
| MXPA03007397A (es) | 2001-02-20 | 2003-12-04 | Bristol Myers Squibb Co | Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas. |
| EP2086935A1 (de) * | 2006-10-16 | 2009-08-12 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
| DE102006049452A1 (de) | 2006-10-17 | 2008-05-08 | Grünenthal GmbH | Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln |
| JP2012506395A (ja) | 2008-10-24 | 2012-03-15 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 痛み、てんかん、及び尿失禁の治療のためのｋｃｎｑ２／３モジュレーターとしての置換された４，５，６，７−テトラヒドロチエノピリジン |
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| CA2815131C (en) * | 2010-10-20 | 2020-06-09 | Gruenenthal Gmbh | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
-
2013
- 2013-04-17 DK DK13719386.8T patent/DK2888233T3/en active
- 2013-04-17 BR BR112014025840A patent/BR112014025840A2/pt not_active IP Right Cessation
- 2013-04-17 HK HK15111080.1A patent/HK1210173A1/xx unknown
- 2013-04-17 HR HRP20161424TT patent/HRP20161424T1/hr unknown
- 2013-04-17 ES ES13719386.8T patent/ES2605947T3/es active Active
- 2013-04-17 LT LTEP13719386.8T patent/LT2888233T/lt unknown
- 2013-04-17 AU AU2013248637A patent/AU2013248637A1/en not_active Abandoned
- 2013-04-17 PT PT137193868T patent/PT2888233T/pt unknown
- 2013-04-17 EP EP13719386.8A patent/EP2888233B1/en not_active Not-in-force
- 2013-04-17 HU HUE13719386A patent/HUE030859T2/en unknown
- 2013-04-17 JP JP2015506121A patent/JP6033403B2/ja not_active Expired - Fee Related
- 2013-04-17 CN CN201380019282.3A patent/CN104428287A/zh active Pending
- 2013-04-17 EA EA201401142A patent/EA201401142A1/ru unknown
- 2013-04-17 SI SI201330394A patent/SI2888233T1/sl unknown
- 2013-04-17 RS RS20161120A patent/RS55466B1/sr unknown
- 2013-04-17 WO PCT/EP2013/001134 patent/WO2013156154A1/en not_active Ceased
- 2013-04-17 CA CA2870573A patent/CA2870573A1/en not_active Abandoned
- 2013-04-17 MX MX2014012494A patent/MX2014012494A/es unknown
- 2013-04-18 AR ARP130101283A patent/AR090739A1/es unknown
-
2014
- 2014-10-07 IL IL235030A patent/IL235030A0/en unknown
-
2016
- 2016-11-24 CY CY20161101222T patent/CY1118255T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013156154A1 (en) | 2013-10-24 |
| EP2888233B1 (en) | 2016-09-28 |
| AR090739A1 (es) | 2014-12-03 |
| CN104428287A (zh) | 2015-03-18 |
| AU2013248637A1 (en) | 2014-12-04 |
| BR112014025840A2 (pt) | 2017-07-18 |
| CA2870573A1 (en) | 2013-10-24 |
| JP2015514728A (ja) | 2015-05-21 |
| JP6033403B2 (ja) | 2016-11-30 |
| EA201401142A1 (ru) | 2015-03-31 |
| CY1118255T1 (el) | 2017-06-28 |
| HK1210173A1 (en) | 2016-04-15 |
| DK2888233T3 (en) | 2017-01-09 |
| SI2888233T1 (sl) | 2016-12-30 |
| HUE030859T2 (en) | 2017-06-28 |
| EP2888233A1 (en) | 2015-07-01 |
| PT2888233T (pt) | 2017-01-04 |
| MX2014012494A (es) | 2015-01-15 |
| ES2605947T3 (es) | 2017-03-17 |
| RS55466B1 (sr) | 2017-04-28 |
| LT2888233T (lt) | 2017-01-10 |
| IL235030A0 (en) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01830A (enExample) | ||
| NZ594928A (en) | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy | |
| NZ593030A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| NZ610689A (en) | Substituted 6-amino-nicotinamides as kcnq2/3 modulators | |
| PH12015501661A1 (en) | Pyridone amides as modulators of sodium channels | |
| FI2291080T5 (fi) | Uusia sfingosiinifosfaattireseptorimodulaattoreita | |
| RU2015143906A (ru) | Замещенные триазолопиридины и способы их применения | |
| RU2015115064A (ru) | Композиции для непрерывного введения ингибиторов допа-декарбоксилазы | |
| NZ596585A (en) | Isoxazolines as inhibitors of fatty acid amide hydrolase | |
| HRP20211282T1 (hr) | Oksisteroli i postupci njihovog korištenja | |
| PH12021550674A1 (en) | Protein tyrosine phosphatase inhibitors | |
| MX336505B (es) | Metodos y composiciones para reducir la grasa y los adipocitos del cuerpo. | |
| MX2013010171A (es) | Antagonistas del receptor de interleucina-1. | |
| RU2011147201A (ru) | Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы | |
| EP2526099A4 (en) | IMPROVED METHOD FOR THE MANUFACTURE OF AMID INTERMEDIATE PRODUCTS AND ITS APPLICATION | |
| TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
| HRP20150526T1 (hr) | Supstituirani 2-oksi-kinolin-3-karboksamidi kao modulatori kcnq2/3 | |
| IN2012DN02502A (enExample) | ||
| MX2012008413A (es) | Composicion novedosa de retigabina. | |
| IN2013DN02555A (enExample) | ||
| HRP20100113T1 (hr) | Upotreba pripravaka koji sadrže antagonist kapa-opioidnog receptora, namijenjenih liječenju disocijativnih poremećaja | |
| EP4470611A3 (en) | Levodopa and carbidopa intestinal gel and methods of use | |
| MX2025014276A (es) | Heterociclos biciclicos 5,6 insaturados utiles como inhibidores de la proteina receptora 3 similar a nod | |
| HRP20150520T1 (hr) | Supstituirani 2-okso- i 2-tiokso-dihidrokinolin-3-karboksamidi kao modulatori kcnq2/3 | |
| RU2590977C2 (ru) | Производные n-ациламинокислот для лечения таких патологий кожи, как целлюлит |